AMPA receptor involvement in 5-hydroxytryptamine2A receptor-mediated pre-frontal cortical excitatory synaptic currents and DOI-induced head shakes-Reference-Cited by-同舟云学术

AMPA receptor involvement in 5-hydroxytryptamine2A receptor-mediated pre-frontal cortical excitatory synaptic currents and DOI-induced head shakes

Published:2008-01 Issue:1 Volume:32 Page:62-71
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Zhang Ce,Marek Gerard J.

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference72 articles.

1. The NMDA antagonist model for schizophrenia: promise and pitfalls;Abi-Saab;Pharmacopsychiatry,1998

2. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells;Aghajanian;Neuropharmacology,1997

3. Serotonin–glutamate interactions: a new target for antipsychotic drugs;Aghajanian;Neuropsychopharmacology,1999

4. Intracellular studies in the facial nucleus illustrating a simple new method for obtaining viable motoneurons in adult rat brain slices;Aghajanian;Synapse,1989

5. Benneyworth MA, Garcia E, Smith R, Sanders-Bush E. (2006). Modulation of hallucinogenic drug action by the mGlu2 subtype of metabotropic glutamate receptors. 2006 Neuroscience Meeting Planner. Atlanta, GA, Society for Neuroscience: Program # 197.19.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antidepressant and anxiolytic effects of activating 5HT2A receptors in the anterior cingulate cortex and the theoretical mechanisms underlying them – A scoping review of available literature;Brain Research;2025-01

2. 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI): From an Obscure to Pivotal Member of the DOX Family of Serotonergic Psychedelic Agents – A Review;ACS Pharmacology & Translational Science;2024-05-08

3. Bio-Psycho-Spiritual Perspectives on Psychedelics: Clinical and Ethical Implications;Perspectives in Biology and Medicine;2024-01

4. Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders;Molecular Psychiatry;2023-11-09

5. A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics;Biology;2023-10-28